Burdeĭnyĭ A P, Solov'ev S K, Timofeeva E B
Ter Arkh. 1987;59(4):84-6.
Pulse-therapy with 6-methylprednisolone was provided to 12 patients (4 with Bekhterev's disease--BD resistant to indomethacin, voltaren and phenylbutazone therapy, 8 with psoriatic arthritis--PA). The drug was injected i.v. at a dose of 1000 mg for 3 days running. A rapid analgetic and antiinflammatory effect was noted in both groups. Ten patients (3 with BD and 8 with PA) demonstrated considerable improvement, 2 improvement. A positive trend in all indices of therapeutic efficacy was noted. In BD change in 33% of indices was statistically significant, in PA in 76%. A decrease in initially elevated serum IgG concentrations in both groups was statistically insignificant. The content of IgM and IgA before treatment was within normal, and the change resulting from pulse-therapy was statistically insignificant. A decrease in initially elevated levels of blood serum circulating immune complexes was statistically significant in both groups. Pulse-therapy was well tolerated.
对12例患者进行了6-甲基泼尼松龙冲击治疗(4例患有对消炎痛、扶他林和保泰松治疗耐药的贝赫捷列夫病——BD,8例患有银屑病关节炎——PA)。药物通过静脉注射,连续3天,剂量为1000毫克。两组均观察到快速的镇痛和抗炎作用。10例患者(3例BD和8例PA)有显著改善,2例有所改善。治疗效果的所有指标均呈现积极趋势。在BD中,33%的指标变化具有统计学意义,在PA中为76%。两组中最初升高的血清IgG浓度下降无统计学意义。治疗前IgM和IgA含量正常,冲击治疗导致的变化无统计学意义。两组中最初升高的血清循环免疫复合物水平下降具有统计学意义。冲击治疗耐受性良好。